HCPCS drug code · CMS crosswalk
Cisplatin J-Code / HCPCS Code
In short
Cisplatin is billed under HCPCS J9060 — Injection, cisplatin, powder or solution, 10 mg. One billing unit is 10 mg. CMS's crosswalk lists 19 Cisplatin NDCs under this code.
Reference
- J9060
- Injection, cisplatin, powder or solution, 10 mgBilling unit: 10 mg
- Labelers
- Accord Healthcare Inc; Apotex Corp; BluePoint Laboratories; Fosun Pharma USA Inc.; FreseniUS Kabi USA, LLC; Hikma Pharmaceuticals USA Inc.; Sagent Pharmaceuticals; Teva Parenteral Medicines, Inc.and 1 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Cisplatin units and claim line
Enter the dose given to get the J9060 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Cisplatin NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9504-01 | J9060 | Hikma Pharmaceuticals USA Inc. | 50 | 5 |
| 00143-9505-01 | J9060 | Hikma Pharmaceuticals USA Inc. | 100 | 10 |
| 00703-5747-11 | J9060 | Teva Parenteral Medicines, Inc. | 50 | 5 |
| 00703-5748-11 | J9060 | Teva Parenteral Medicines, Inc. | 100 | 10 |
| 16729-0288-11 | J9060 | Accord Healthcare Inc | 50 | 5 |
| 16729-0288-38 | J9060 | Accord Healthcare Inc | 100 | 10 |
| 25021-0253-50 | J9060 | Sagent Pharmaceuticals | 50 | 5 |
| 25021-0253-51 | J9060 | Sagent Pharmaceuticals | 100 | 10 |
| 44567-0511-01 | J9060 | WG Critical Care, LLC | 200 | 20 |
| 44567-0530-01 | J9060 | WG Critical Care, LLC | 1 | 5 |
| 60505-6279-00 | J9060 | Apotex Corp | 50 | 5 |
| 63323-0103-51 | J9060 | FreseniUS Kabi USA, LLC | 50 | 5 |
| 63323-0103-64 | J9060 | FreseniUS Kabi USA, LLC | 200 | 20 |
| 63323-0103-65 | J9060 | FreseniUS Kabi USA, LLC | 100 | 10 |
| 68001-0283-32 | J9060 | BluePoint Laboratories | 100 | 10 |
| 68001-0608-24 | J9060 | BluePoint Laboratories | 50 | 5 |
| 68001-0609-33 | J9060 | BluePoint Laboratories | 100 | 10 |
| 72266-0252-01 | J9060 | Fosun Pharma USA Inc. | 50 | 5 |
| 72266-0253-01 | J9060 | Fosun Pharma USA Inc. | 100 | 10 |
Cisplatin: common questions
- What is the J-code for Cisplatin?
- Cisplatin is billed under HCPCS J9060 — Injection, cisplatin, powder or solution, 10 mg. One billing unit is 10 mg. CMS's crosswalk lists 19 Cisplatin NDCs under this code.
- How many J9060 billing units are in a package of Cisplatin?
- CMS lists 5 to 20 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- Is J9060 a CPT code?
- No. J9060 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.